John Hoskins Stone

John Hoskins Stone John Hoskins Stone (July 17, 1749 – October 5, 1804) was an American planter, soldier, and politician from Charles County, Maryland. During the Revolutionary War he led the 1st Maryland Regiment of the Continental Army. After the war he served in the state legislature and was the seventh Governor from 1794 to 1797. Provided by Wikipedia
Showing 1 - 20 results of 22 for search 'John H. Stone', query time: 0.06s Refine Results
  1. 1
    Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

    Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide? by Zachary S. Wallace, Zachary S. Wallace, Zachary S. Wallace, Zachary S. Wallace, John H. Stone, John H. Stone, John H. Stone

    Published 2019-12-01
    Get full text
    Article
  2. 2
    Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease

    Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease by Hamid Mattoo, John H. Stone, Shiv Pillai

    Published 2017-01-01
    Get full text
    Article
  3. 3
    Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial

    Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial by Naomi J. Patel, Xiaoqing Fu, Yuqing Zhang, John H. Stone

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial

    Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial by Vibeke Strand, Sophie Dimonaco, Katie Tuckwell, Micki Klearman, Neil Collinson, John H. Stone

    Published 2019-02-01
    Get full text
    Article
  5. 5
    Validation of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis as the Cause of End‐Stage Renal Disease in the US Renal Data System

    Validation of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis as the Cause of End‐Stage Renal Disease in the US Renal Data System by Claire E. Cook, Xiaoqing Fu, Yuqing Zhang, John H. Stone, Hyon K. Choi, Zachary S. Wallace

    Published 2022-01-01
    Get full text
    Article
  6. 6
    Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic

    Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic by Claire Cook, Huel Cox, Xiaoqing Fu, Yuqing Zhang, John H. Stone, Hyon K. Choi, Zachary S. Wallace

    Published 2021-12-01
    Get full text
    Article
  7. 7
    Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis

    Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis by Zachary S. Wallace, Tyler Harkness, Kimberly G. Blumenthal, Hyon K. Choi, John H. Stone, Rochelle P. Walensky

    Published 2020-05-01
    Get full text
    Article
  8. 8
    Derivation and Validation of Algorithms to Identify Patients With Immunoglobulin‐G4‐Related Disease Using Administrative Claims Data

    Derivation and Validation of Algorithms to Identify Patients With Immunoglobulin‐G4‐Related Disease Using Administrative Claims Data by Zachary S. Wallace, Xiaoqing Fu, Claire Cook, Cory A. Perugino, Yuqing Zhang, John H. Stone, Hyon K. Choi

    Published 2022-04-01
    Get full text
    Article
  9. 9
    Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data

    Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data by Sara Gale, Huong Trinh, Katie Tuckwell, Neil Collinson, John H. Stone, Khaled Sarsour, Jinglan Pei, Jennie Best, Christine Birchwood, Shalini V. Mohan

    Published 2019-02-01
    Get full text
    Article
  10. 10
    Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

    Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations by Sebastian Unizony, Timothy J. McCulley, Robert Spiera, Jinglan Pei, Paris N. Sidiropoulos, Jennie H. Best, Christine Birchwood, Andrey Pavlov, John H. Stone

    Published 2021-01-01
    Get full text
    Article
  11. 11
    Treatment of IgG4-related disease-associated hypertrophic pachymeningitis with intrathecal rituximab: a case report

    Treatment of IgG4-related disease-associated hypertrophic pachymeningitis with intrathecal rituximab: a case report by Denis T. Balaban, Spencer K. Hutto, Bruno P. Panzarini, Aileen O'Shea, Aditi Varma, Pamela S. Jones, Bart K. Chwalisz, Bart K. Chwalisz, John H. Stone, Nagagopal Venna

    Published 2023-05-01
    Get full text
    Article
  12. 12
    Pulmonary and coronary arterial abnormalities in patients with IgG4-related disease

    Pulmonary and coronary arterial abnormalities in patients with IgG4-related disease by Rory L. Cochran, MD, PhD, Holly R. Brideau, MD, MS, Markus Y. Wu, MD, John H. Stone, MD, MPH, Zachary S. Wallace, MD, MSc, Brent P. Little, MD

    Published 2022-12-01
    Get full text
    Article
  13. 13
    Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort studyCapsule Summary

    Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort studyCapsule Summary by Yicong Liang, MD, Faith A.P. Zeng, Tabrez Sheriff, MD, Anna Wilson, MD, Asli Bilgic, MD, Grant Feng, John H. Stone, MD, MPH, Dedee F. Murrell, MA, BMBCh, MD

    Published 2022-03-01
    Get full text
    Article
  14. 14
    Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

    Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial by Cory Perugino, Emma L. Culver, Arezou Khosroshahi, Wen Zhang, Emanuel Della-Torre, Kazuichi Okazaki, Yoshiya Tanaka, Matthias Löhr, Nicolas Schleinitz, Judith Falloon, Dewei She, Daniel Cimbora, John H. Stone

    Published 2023-10-01
    Get full text
    Article
  15. 15
    Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis

    Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis by Damian R. Plichta, Juhi Somani, Matthieu Pichaud, Zachary S. Wallace, Ana D. Fernandes, Cory A. Perugino, Harri Lähdesmäki, John H. Stone, Hera Vlamakis, Daniel C. Chung, Dinesh Khanna, Shiv Pillai, Ramnik J. Xavier

    Published 2021-02-01
    Get full text
    Article
  16. 16
    Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren’s syndrome

    Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren’s syndrome by Naoki Kaneko, Hu Chen, Cory A. Perugino, Takashi Maehara, Ryusuke Munemura, Shiho Yokomizo, Junsei Sameshima, Thomas J. Diefenbach, Katherine R. Premo, Akira Chinju, Yuka Miyahara, Mizuki Sakamoto, Masafumi Moriyama, John H. Stone, Seiji Nakamura, Shiv Pillai

    Published 2022-09-01
    Get full text
    Article
  17. 17
    A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

    A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis by Wolfgang A. Schmidt, Bhaskar Dasgupta, Jennifer Sloane, Angeliki Giannelou, Yuqing Xu, Sebastian H. Unizony, Sarah L. Mackie, Miguel A. Gonzalez-Gay, Robert Spiera, Kenneth J. Warrington, Peter M. Villiger, Michael C. Nivens, Bolanle Akinlade, Yong Lin, Frank Buttgereit, John H. Stone

    Published 2023-10-01
    Get full text
    Article
  18. 18
    Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism

    Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism by John H Stone, Peter C Grayson, Ulrich Specks, E William St Clair, Peter A Merkel, Philip Seo, Carol A Langford, Paul A Monach, Cees G M Kallenberg, Robert F Spiera, Fernando C Fervenza, Zuoming Deng, Wei Tew, Marta Casal Moura, Stephen R Brooks, Marco Prunotto

    Published 2023-03-01
    Get full text
    Article
  19. 19
    Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis

    Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis by Gwen E. Thompson, Gwen E. Thompson, Lynn A. Fussner, Amber M. Hummel, Darrell R. Schroeder, Francisco Silva, Melissa R. Snyder, Carol A. Langford, Peter A. Merkel, Peter A. Merkel, Paul A. Monach, Philip Seo, Robert F. Spiera, E. William St. Clair, John H. Stone, Ulrich Specks

    Published 2020-09-01
    Get full text
    Article
  20. 20
    Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis.

    Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis. by Paul A Monach, Philipp Kümpers, Alexander Lukasz, Gunnar Tomasson, Ulrich Specks, John H Stone, David Cuthbertson, Jeffrey Krischer, Simon Carette, Linna Ding, Gary S Hoffman, David Iklé, Cees G M Kallenberg, Nader A Khalidi, Carol A Langford, Philip Seo, E William St Clair, Robert Spiera, Nadia Tchao, Steven R Ytterberg, Marion Haubitz, Peter A Merkel

    Published 2012-01-01
    Get full text
    Article

Search Tools: